Invest A/S Lundbeckfond
CIK 1591046 · last filed 2023-11-09
Invest A/S Lundbeckfond is a corporate insider who has filed 7 SEC Form 4 insider transactions across 6 companies since 2014. The most recent filing, for LXEO, was dated Nov 9, 2023. Across all open-market trades the lifetime net is +$49.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $43.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$43.44M
6
7
$49.88M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LXEO | 10%+ Owner | 1,835,959 | $4.37 | $8.02M | $2.50M | 1 | 2023-11-09 |
| IO Biotech, Inc. (IOBT) Delisted | Director | 13,950,686 | $0.05 | $669.6K | $30.00M | 2 | 2023-08-11 |
| IMRA | 10%+ Owner | 1,432,722 | $17.02 | $24.38M | $3.00M | 1 | 2020-03-16 |
| TRVI | 10%+ Owner | 776,544 | $14.21 | $11.03M | $3.75M | 1 | 2019-05-13 |
| scPharmaceuticals Inc. (SCPH) Delisted | 10%+ Owner | 1,544,858 | $5.67 | $8.76M | $9.17M | 1 | 2017-11-21 |
| Eiger BioPharmaceuticals, Inc. (CLDN) Delisted | 10%+ Owner | 1,544,397 | — | — | $1.46M | 1 | 2014-02-06 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-09 | LXEO | Mixed | +1,835,959 | $2.50M | EDGAR |
| 2023-08-11 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | +7,901,234 | $15.01M | EDGAR |
| 2021-11-12 | IO Biotech, Inc. (IOBT) Delisted | Mixed | +6,049,452 | $30.00M | EDGAR |
| 2020-03-16 | IMRA | Mixed | +1,432,722 | $3.00M | EDGAR |
| 2019-05-13 | TRVI | Mixed | +1,151,544 | $3.75M | EDGAR |
| 2017-11-21 | scPharmaceuticals Inc. (SCPH) Delisted | Mixed | +3,183,986 | $9.17M | EDGAR |
| 2014-02-06 | Eiger BioPharmaceuticals, Inc. (CLDN) Delisted | Mixed | +1,745,683 | $1.61M | EDGAR |